• Oxurion NV appoints Tom Graney, CFA as Chief Financial Officer

    Wednesday October 14th 2020

  • Bone Therapeutics’ allogeneic cell therapy product, ALLOB, shows 90% fusion rate at 24 months in Phase IIa study in lumbar spinal fusion

    Wednesday October 14th 2020

  • Phase 2B/3 Trial shows efficacy of Filgotinib for the induction and maintenance of remission in moderately and severely active Ulcerative Colitis

    Tuesday October 13th 2020

  • Sanquin finds investors for plasma-derived medicines manufacturing subsidiaries Plasma Industries and Plasma Products

    Tuesday October 13th 2020

  • BISC Global awarded a Eurostars grant for the development of a machine learning based antigen discovery and T-cell epitope prediction software.

    Friday October 9th 2020

  • eTheRNA strengthens senior management team with appointment of Michael Mulqueen as VP Business Development

    Thursday October 8th 2020

  • Complix receives €1.2 million VLAIO grant to develop a novel and differentiated class of anti-Covid-19 Alphabody™ therapeutics

    Wednesday October 7th 2020

  • CRISPRing trees for a climate-friendly economy

    Wednesday October 7th 2020

  • Your news here?

  • Biocartis announces market release of SeptiCyte® RAPID test on Idylla™

    Tuesday October 6th 2020

  • Mithra announces FDA update

    Tuesday October 6th 2020

  • argenx expands capabilities in antibody engineering through key technology partnerships

    Tuesday October 6th 2020


Strategic Partners